Liaison Technologies Announces Partnership with SAFE-BioPharma®
ATLANTA–()–Liaison Technologies, a global provider of secure cloud-based integration and data management services and solutions, announced today a partnership with SAFE-BioPharma Association. As a result, Liaison’s clients and their partners can leverage the validation and security of the SAFE-BioPharma® digital identity and signature standard, which verifies and manages digital identities and signatures involved in electronic transactions.
“Liaison’s enablement of the SAFE-BioPharma standard in a cloud-based platform is important to life sciences organizations as they utilize this important technology,” said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association.
This standard was designed to speed transformation of the biopharmaceutical and healthcare communities to a fully digital environment, while mitigating legal, regulatory and other business risk associated with electronic transactions. Recognized by the Drug Enforcement Agency (DEA) and in-line with HIPAA regulations, the standard provides a way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions.
“Collaborating with SAFE-BioPharma shows an ongoing commitment to ensuring our cloud-based services are supported by industry standards that enhance the quality and security of patient and other sensitive data,” said Gary Palgon, Liaison’s vice president of healthcare solutions. “This partnership adds to other important relationships in our healthcare partner program that benefit our clients and support the services we provide.”
Liaison announced a healthcare partner program earlier this year in an effort to expand services available to clients so they can more easily exchange information in light of the HITECH Act and new models of care in addition to taking advantage of data for the purposes of secondary use.
About Liaison Technologies
Liaison Technologies is a global integration, data management and data security company. It provides unique and high-value services to move, transform and manage business information in the cloud, and to protect data to help organizations master complex security challenges and meet compliance mandates. With a comprehensive array of business-to-business and application-to-application integration and data transformation services, as well as on-premise and cloud-based data security solutions, Liaison’s practitioners implement data management infrastructures adapted to each client’s specific business requirements. Headquartered in Atlanta, Liaison has offices in the Netherlands, Finland, Sweden and the United Kingdom. For more information, visit www.liaison.com.
About SAFE-BioPharma
SAFE-BioPharma is the global industry standard for digital trust. It was developed by a non-profit consortium of biopharmaceutical and related companies to transition the biopharmaceutical and healthcare communities to paperless environments. For more information, visit: http://www.safe-biopharma.org.
Liaison and the Liaison logo are trademarks of Liaison Technologies, Inc. All other names or product names mentioned in this release are trademarks or registered trademarks of their respective companies.
SAFE-BioPharma® is a registered trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.
